Teleflex Unites its World-Class Arrow®, Hudson RCI®, LMA® and Rusch® Brands at AARC 2014
04 December 2014 - 1:00AM
Business Wire
Innovation with a Purpose: Leading the Way to
Advance Respiratory Care
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical devices for critical care and surgery, will be featuring
medical technology designed to improve patient outcomes and reduce
healthcare costs at the American Association for Respiratory Care
(AARC) Congress 2014, Dec. 9-12 in Las Vegas.
“At Teleflex, we are dedicated to solving unmet clinical needs
and delivering positive outcomes for patients and clinicians,” said
James Ferguson, President, Respiratory Division, Teleflex. “We have
united trusted brands, products and technology to help clinicians
lead the way to advance respiratory care. We look forward to
sharing the value of choosing Teleflex as a preferred partner with
the entire respiratory therapy community.”
At the meeting, Teleflex will showcase the Hudson RCI® Neptune®
Heated Humidifier with ConchaSmart® Technology offering
best-in-class features such as low water notification and an Auto
Settings mode. This innovative humidification platform provides a
simple, smart, practical solution to meet the unique needs of
patients, while helping clinicians manage time and money.
The new ISO-Gard® Mask with ClearAir™ Technology will also be
featured at the meeting. A recent study published in the Journal of
PeriAnesthesia Nursing (JOPAN) reported occupational exposure to
waste anesthetic gases (WAG) in the post-anesthesia care unit
(PACU) may be higher than standards recommend. The study evaluated
and demonstrated that perianesthesia nurses are exposed to
significantly less WAG when patients wear the ISO-Gard® Mask with
ClearAir™ Technology from Teleflex, compared to a standard cannula
or face tent.1
The Softech® Plus ETCO2 Sampling Cannula will be showcased at
the meeting. The American Society of Anesthesiologists (ASA) has
developed standards for basic anesthetic monitoring and recommends
patient monitoring of CO2 during moderate or deep sedation. The
Softech® Plus Sampling Cannula uses a divided design to deliver
oxygen from one nare and sample carbon dioxide from the other,
permitting an undiluted end tidal gas sample.
Teleflex is a corporate partner of the AARC and will be hosting
a Photo Challenge at the Teleflex booth #840, with proceeds
benefiting the American Respiratory Care Foundation (ARCF) and the
International Council for Respiratory Care, a charitable
organization of the ARCF.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical
devices for a range of procedures in critical care and surgery. Our
mission is to provide solutions that enable healthcare providers to
improve outcomes and enhance patient and provider safety.
Headquartered in Wayne, PA, Teleflex employs approximately 11,500
people worldwide and serves healthcare providers in more than 150
countries. Additional information about Teleflex can be obtained
from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, Arrow, ClearAir, ConchaSmart, Hudson RCI, ISO-Gard,
LMA, Neptune, Rusch and Softech are trademarks or registered
trademarks of Teleflex Incorporated or its affiliates.© 2014
Teleflex Incorporated. All rights reserved. MC-000450
Reference:
1. McGlothlin JD, Moenning JE, Cole, SS. Evaluation and Control
of Waste Anesthetic Gases in the Postanesthesia Care Unit. Journal
of PeriAnesthesia Nursing Volume 29, Issue 4, Pages 298-312, August
2014.
This study was funded in part by a grant from Teleflex. A
pre-market version of the ISO-Gard Mask was studied. The IRB study
was not an outcome study to support an FDA submission.
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor
Relations610-948-2836jake.elguicze@teleflex.comwww.teleflex.com
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2024 to May 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From May 2023 to May 2024